{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:30:19Z","timestamp":1778117419303,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.apradiso.2024.111636","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T07:42:06Z","timestamp":1734075726000},"page":"111636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Monte Carlo investigation of dose distribution of two model 106Ru\/106Rh ophthalmic plaques in a realistic human eye model with different uveal melanoma size"],"prefix":"10.1016","volume":"217","author":[{"given":"Zeinab","family":"Fardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-6219","authenticated-orcid":false,"given":"Payvand","family":"Taherparvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apradiso.2024.111636_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meddos.2010.12.003","article-title":"The effects of variations in the density and composition of eye materials on ophthalmic brachytherapy dosimetry","volume":"37","author":"Asadi","year":"2012","journal-title":"Med. Dosim."},{"key":"10.1016\/j.apradiso.2024.111636_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.radphyschem.2012.12.025","article-title":"Brachytherapy treatment simulation of strontium-90 and ruthenium-106 plaques on small size posterior uveal melanoma using MCNPX code","volume":"95","author":"Barbosa","year":"2014","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.apradiso.2024.111636_bib3","doi-asserted-by":"crossref","DOI":"10.14319\/ijcto.0203.8","article-title":"Assessment of ocular beta radiation dose distribution due to 106Ru\/106Rh brachytherapy applicators using MCNPX Monte Carlo code","volume":"2","author":"Barbosa","year":"2014","journal-title":"Int. J. Cancer Ther. Oncol."},{"key":"10.1016\/j.apradiso.2024.111636_bib4","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1088\/0031-9155\/54\/13\/008","article-title":"Dose conversion coefficients for electron exposure of the human eye lens","volume":"54","author":"Behrens","year":"2009","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.apradiso.2024.111636_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1118\/1.1333412","article-title":"Measurements and Monte Carlo calculations to determine the absolute detector response of radiochromic film for brachytherapy dosimetry","volume":"28","author":"Bohm","year":"2001","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.rpor.2014.01.001","article-title":"A Monte Carlo evaluation for effects of probable dimensional uncertainties of low dose rate brachytherapy seeds on dose","volume":"19","author":"Camg\u00f6z","year":"2014","journal-title":"Rep. Practical Oncol. Radiother."},{"key":"10.1016\/j.apradiso.2024.111636_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1088\/0031-9155\/20\/2\/002","article-title":"Dimensions of the human eye relevant to radiation protection (dosimetry)","volume":"20","author":"Charles","year":"1975","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.apradiso.2024.111636_bib8","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib9","series-title":"Dosimetry of Beta Rays and Low-Energy Photons for Brachytherapy with Sealed Sources, ICRU Report 72","author":"Cross","year":"2004"},{"key":"10.1016\/j.apradiso.2024.111636_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2005.02.059","article-title":"Visual acuity after Ruthenium106 brachytherapy of choroidal melanomas","volume":"63","author":"Damato","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2478\/pjmpe-2019-0003","article-title":"A Monte Carlo investigation of the dose distribution for new I-125 Low Dose Rate brachytherapy source in water and in different media","volume":"25","author":"Fardi","year":"2019","journal-title":"Pol. J. Med. Phys. Eng."},{"key":"10.1016\/j.apradiso.2024.111636_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","author":"Force","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.apradiso.2024.111636_bib13","series-title":"Seminars in Surgical Oncology","first-page":"167","article-title":"Brachytherapy in primary ocular tumors","author":"Freire","year":"1997"},{"key":"10.1016\/j.apradiso.2024.111636_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","article-title":"Design and methods of a clinical trial for a rare condition: the collaborative ocular melanoma study: COMS report No. 3","volume":"14","year":"1993","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.apradiso.2024.111636_bib15","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.radmeas.2011.07.032","article-title":"3D dosimetry on Ru-106 plaque for ocular melanoma treatments","volume":"46","author":"Gueli","year":"2011","journal-title":"Radiat. Meas."},{"key":"10.1016\/j.apradiso.2024.111636_bib16","doi-asserted-by":"crossref","DOI":"10.1118\/1.4820368","article-title":"Calculation of dose distributions for 12 106Ru\/106Rh ophthalmic applicator models with the PENELOPE Monte Carlo code","volume":"40","author":"Hermida\u2010L\u00f3pez","year":"2013","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-020-01621-4","article-title":"106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma","volume":"15","author":"Jiang","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.apradiso.2024.111636_bib18","doi-asserted-by":"crossref","DOI":"10.1118\/1.4861715","article-title":"Model\u2010based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom","volume":"41","author":"Lesperance","year":"2014","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib19","first-page":"372","article-title":"Experimental radiation cataract--its clinical relevance","volume":"59","author":"Merriam","year":"1983","journal-title":"Bull. N. Y. Acad. Med."},{"key":"10.1016\/j.apradiso.2024.111636_bib20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejmp.2016.07.636","article-title":"Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform","volume":"32","author":"Mostafa","year":"2016","journal-title":"Phys. Med."},{"key":"10.1016\/j.apradiso.2024.111636_bib21","series-title":"Monte Carlo Simulation of Two 106Ru Eye Plaques in a New Mathematical Human Eye Model","author":"Moulavi","year":"2008"},{"key":"10.1016\/j.apradiso.2024.111636_bib22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib23","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1088\/0031-9155\/56\/21\/010","article-title":"Dose conversion coefficients for monoenergetic electrons incident on a realistic human eye model with different lens cell populations","volume":"56","author":"Nogueira","year":"2011","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.apradiso.2024.111636_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000328254","article-title":"Ruthenium-106 brachytherapy","volume":"49","author":"Pe\u2019er","year":"2012","journal-title":"Current concepts in uveal melanoma"},{"key":"10.1016\/j.apradiso.2024.111636_bib25","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1118\/1.1759826","article-title":"Phantom size in brachytherapy source dosimetric studies","volume":"31","author":"P\u00e9rez-Calatayud","year":"2004","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.zemedi.2012.07.005","article-title":"EduGATE\u2013basic examples for educative purpose using the GATE simulation platform","volume":"23","author":"Pietrzyk","year":"2013","journal-title":"Z. Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5114\/jcb.2019.83002","article-title":"Monte Carlo dosimetry for a new 32P brachytherapy source using FLUKA code","volume":"11","author":"Rajabi","year":"2019","journal-title":"J. Contemp. Brachytherapy"},{"key":"10.1016\/j.apradiso.2024.111636_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","article-title":"Incidence of uveal melanoma in the United States: 1973\u20131997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apradiso.2024.111636_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5114\/jcb.2017.68761","article-title":"INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures","volume":"9","author":"Tagliaferri","year":"2017","journal-title":"J. Contemp. Brachytherapy"},{"key":"10.1016\/j.apradiso.2024.111636_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s13139-020-00680-5","article-title":"Development of GATE Monte Carlo code for simulation and dosimetry of new I-125 seeds in eye plaque brachytherapy","volume":"55","author":"Taherparvar","year":"2021","journal-title":"Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.apradiso.2024.111636_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110146","article-title":"Comparison between dose distribution from 103Pd, 131Cs, and 125I plaques in a real human eye model with different tumor size","volume":"182","author":"Taherparvar","year":"2022","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2024.111636_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13246-017-0607-6","article-title":"Development of GATE Monte Carlo simulation for a CsI pixelated gamma camera dedicated to high resolution animal SPECT","volume":"41","author":"Taherparvar","year":"2018","journal-title":"Australas. Phys. Eng. Sci. Med."},{"key":"10.1016\/j.apradiso.2024.111636_bib34","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2024.111636_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1051\/radiopro\/2016022","article-title":"Dose calculation of different eye substructures using a realistic eye model when treating ocular tumors with electron therapy","volume":"51","author":"Vejdani-Noghreiyan","year":"2016","journal-title":"Radioprotection"},{"key":"10.1016\/j.apradiso.2024.111636_bib36","series-title":"The Edward S Harkness Eye Institute Resident's Basic Science Study Guide","author":"Worgul","year":"1991"},{"key":"10.1016\/j.apradiso.2024.111636_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/rpd\/nci105","article-title":"A new human eye model for ophthalmic brachytherapy dosimetry","volume":"115","author":"Yoriyaz","year":"2005","journal-title":"Radiat. Protect. Dosim."},{"key":"10.1016\/j.apradiso.2024.111636_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000492599","article-title":"Monte Carlo simulation of the treatment of uveal melanoma using measured heterogeneous 106Ru plaques","volume":"5","author":"Zaragoza","year":"2019","journal-title":"Ocular oncology and pathology"}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804324004640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804324004640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T06:22:00Z","timestamp":1737613320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804324004640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"alternative-id":["S0969804324004640"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2024.111636","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monte Carlo investigation of dose distribution of two model 106Ru\/106Rh ophthalmic plaques in a realistic human eye model with different uveal melanoma size","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2024.111636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111636"}}